Seroatlas · Human Serome Atlas

RIPPLY2

Protein ripply2

Also known as: C6orf159, dJ237I15.1, RIPP2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q5TAB7
Gene
RIPPLY2
Ensembl
ENSG00000203877
Chromosome
6
Canonical length
128 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins

OverviewNCBI Gene

This gene encodes a nuclear protein that belongs to a novel family of proteins required for vertebrate somitogenesis. Members of this family have a tetrapeptide WRPW motif that is required for interaction with the transcriptional repressor Groucho and a carboxy-terminal Ripply homology domain/Bowline-DSCR-Ledgerline conserved region required for transcriptional repression. Null mutant mice die soon after birth and display defects in axial skeleton segmentation due to defective somitogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Canonical amino-acid sequenceUniProt

128 residues, UniProt reviewed canonical sequence.

>Q5TAB7|RIPPLY2
     1  MENAGGAEGT ESGAAACAAT DGPTRRAGAD SGYAGFWRPW VDAGGKKEEE TPNHAAEAMP
    61  DGPGMTAASG KLYQFRHPVR LFWPKSKCYD YLYQEAEALL KNFPIQATIS FYEDSDSEDE
   121  IEDLTCEN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against RIPPLY2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.6
Highest tissue expression
32 nTPM

Expression across tissuesHPA

Tissue

  • cerebellum: 32 nTPM
  • basal ganglia: 24 nTPM
  • cerebral cortex: 23 nTPM
  • amygdala: 20 nTPM
  • hippocampal formation: 19 nTPM
  • hypothalamus: 17 nTPM

Single-cell type

  • pancreatic islet cells: 19 nCPM
  • brain excitatory neurons: 17 nCPM
  • retinal ganglion cells: 16 nCPM
  • brain inhibitory neurons: 15 nCPM
  • other brain neurons: 14 nCPM
  • oligodendrocyte progenitor cells: 10 nCPM

Immune cell

  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • cerebellum: 20 nTPM
  • cerebral cortex: 15 nTPM
  • hypothalamus: 13 nTPM
  • basal ganglia: 12 nTPM
  • hippocampal formation: 11 nTPM
  • white matter: 11 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about RIPPLY2.

Disease | AllUniProt

Conditions RIPPLY2 is implicated in, by any mechanism.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 104 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.26
gnomAD pLI
0.01
gnomAD missense Z
-0.56
DepMap mean gene effect
-0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads RIPPLY2 as an antibody target. Whether an autoantibody or antibody against RIPPLY2 could matter depends on whether native RIPPLY2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

RIPPLY2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label RIPPLY2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/RIPPLY2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...